ENZO BIOCHEM, INC. Restricted Stock or Unit Expense
ENZO BIOCHEM, INC. reported Restricted Stock or Unit Expense of $1.77 million for the 12-month period ending 2023-07-31, per its 10-K filed 2024-10-29.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2024-10-29
- ENZO BIOCHEM, INC. restricted stock or unit expense for the quarter ending 2023-07-31 was $1.11M.
- ENZO BIOCHEM, INC. restricted stock or unit expense for the quarter ending 2023-04-30 was $277.00K, a 222.09% increase year-over-year.
- ENZO BIOCHEM, INC. restricted stock or unit expense for the quarter ending 2023-01-31 was $202.00K, a 176.71% increase year-over-year.
- ENZO BIOCHEM, INC. restricted stock or unit expense for the quarter ending 2022-10-31 was $186.00K.
- ENZO BIOCHEM, INC. restricted stock or unit expense for fiscal 2023 was $1.77M.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 6 month | Restricted Stock or Unit Expense 9 month | Restricted Stock or Unit Expense 12 month |
|---|---|---|---|---|
| 2023-07-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-10-29 | $1.38M derived: sum of 2 quarters · filed 2024-10-29 | $1.58M derived: sum of 3 quarters · filed 2024-10-29 | $1.77M 10-K · filed 2024-10-29 |
| 2023-04-30 | $277.00K 10-Q · filed 2023-06-14 | $479.00K derived: sum of 2 quarters · filed 2023-06-14 | $666.00K 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $202.00K 10-Q · filed 2023-03-20 | $388.00K 10-Q · filed 2023-03-20 | ||
| 2022-10-31 | $186.00K 10-Q · filed 2022-12-12 | |||
| 2022-04-30 | $86.00K 10-Q · filed 2023-06-14 | $159.00K derived: sum of 2 quarters · filed 2023-06-14 | $159.00K 10-Q · filed 2023-06-14 | |
| 2022-01-31 | $73.00K 10-Q · filed 2023-03-20 | $73.00K 10-Q · filed 2023-03-20 |